Abstract
The discovery of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas) system, and its development into a set of powerful tools for manipulating the genome, has revolutionized genome editing. Precise, targeted CRISPR/Cas-based genome editing has become the most widely used platform in organisms ranging from plants to animals. The CRISPR/Cas system has been extensively modified to increase its efficiency and fidelity. In addition, the fusion of various protein motifs to Cas effector proteins has facilitated diverse set of genetic manipulations, such as base editing, transposition, recombination, and epigenetic regulation. The CRISPR/Cas system is undergoing continuous development to overcome current limitations, including off-target effects, narrow targeting scope, and issues associated with the delivery of CRISPR components for genome engineering and therapeutic approaches. Here, we review recent progress in a diverse array of CRISPR/Cas-based tools. We also describe limitations and concerns related to the use of CRISPR/Cas technologies.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abudayyeh OO, Gootenberg JS, Konermann S, Joung J, Slaymaker IM, Cox DBT, Shmakov S, Makarova KS, Semenova E, Minakhin L, Severinov K, Regev A, Lander ES, Koonin EV, Zhang F (2016) C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science. https://doi.org/10.1126/science.aaf5573
Anders C, Bargsten K, Jinek M (2016) Structural plasticity of PAM recognition by engineered variants of the RNA-guided endonuclease Cas9. Mol Cell 61:895–902. https://doi.org/10.1016/j.molcel.2016.02.020
Anzalone AV, Randolph PB, Davis JR, Sousa AA, Koblan LW, Levy JM, Chen PJ, Wilson C, Newby GA, Raguram A, Liu DR (2019) Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576:149–157. https://doi.org/10.1038/s41586-019-1711-4
Bae S, Park J, Kim JS (2014) Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics 30:1473–1475. https://doi.org/10.1093/bioinformatics/btu048
Balboa D, Weltner J, Eurola S, Trokovic R, Wartiovaara K, Otonkoski T (2015) Conditionally stabilized dCas9 activator for controlling gene expression in human cell reprogramming and differentiation. Stem Cell Rep 5:448–459. https://doi.org/10.1016/j.stemcr.2015.08.001
Banakar R, Schubert M, Collingwood M, Vakulskas C, Eggenberger AL, Wang K (2020) Comparison of CRISPR-Cas9/Cas12a ribonucleoprotein complexes for genome editing efficiency in the rice phytoene desaturase (OsPDS) gene. Rice 13:4. https://doi.org/10.1186/s12284-019-0365-z
Behan FM, Iorio F, Picco G, Gonçalves E, Beaver CM, Migliardi G, Santos R, Rao Y, Sassi F, Pinnelli M, Ansari R, Harper S, Jackson DA, McRae R, Pooley R, Wilkinson P, van der Meer D, Dow D, Buser-Doepner C, Bertotti A, Trusolino L, Stronach EA, Saez-Rodriguez J, Yusa K, Garnett MJ (2019) Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens. Nature 568:511–516. https://doi.org/10.1038/s41586-019-1103-9
Burmistrz M, Krakowski K, Krawczyk-Balska A (2020) RNA-targeting CRISPR–Cas systems and their applications. Int J Mol Sci. https://doi.org/10.3390/ijms21031122
Chaikind B, Bessen JL, Thompson DB, Hu JH, Liu DR (2016) A programmable Cas9-serine recombinase fusion protein that operates on DNA sequences in mammalian cells. Nucleic Acids Res 44:9758–9770. https://doi.org/10.1093/nar/gkw707
Chapman JR, Taylor MRG, Boulton SJ (2012) Playing the end game: DNA double-strand break repair pathway choice. Mol Cell 47:497–510. https://doi.org/10.1016/j.molcel.2012.07.029
Charlesworth CT, Deshpande PS, Dever DP, Camarena J, Lemgart VT, Cromer MK, Vakulskas CA, Collingwood MA, Zhang L, Bode NM, Behlke MA, Dejene B, Cieniewicz B, Romano R, Lesch BJ, Gomez-Ospina N, Mantri S, Pavel-Dinu M, Weinberg KI, Porteus MH (2019) Identification of preexisting adaptive immunity to Cas9 proteins in humans. Nat Med 25:249–254. https://doi.org/10.1038/s41591-018-0326-x
Chatterjee P, Lee J, Nip L, Koseki SRT, Tysinger E, Sontheimer EJ, Jacobson JM, Jakimo N (2020) A Cas9 with PAM recognition for adenine dinucleotides. Nat Commun. https://doi.org/10.1038/s41467-020-16117-8
Chavez A, Scheiman J, Vora S, Pruitt BW, Tuttle M, Iyer PR, Lin E, Kiani S, Guzman S, Wiegand CD, Ter-Ovanesyan DJ, Braff D, Davidsohn JL, Housden N, Perrimon BE, Weiss N, Aach R, Collins J, Church JJ (2015) Highly efficient Cas9-mediated transcriptional programming. Nat Methods 12:326–328. https://doi.org/10.1038/nmeth.3312
Chen JS, Dagdas YS, Kleinstiver BP, Welch MM, Sousa AA, Harrington LB, Sternberg SH, Joung JK, Yildiz A, Doudna JA (2017) Enhanced proofreading governs CRISPR-Cas9 targeting accuracy. Nature 550:407–410. https://doi.org/10.1038/nature24268
Chen SP, Wang HH (2019) An engineered Cas-transposon system for programmable and site-directed DNA transpositions. Cris J 2:376–394. https://doi.org/10.1089/crispr.2019.0030
Chow RD, Chen JS, Shen J, Chen S (2020) A web tool for the design of prime-editing guide RNAs. Nat Biomed Eng 5:190–194. https://doi.org/10.1038/s41551-020-00622-8
Christian M, Cermak T, Doyle EL, Schmidt C, Zhang F, Hummel A, Bogdanove AJ, Voytas DF (2010) Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 186:757–761. https://doi.org/10.1534/genetics.110.120717
Chu VT, Weber T, Wefers B, Wurst W, Sander S, Rajewsky K, Kühn R (2015) Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells. Nat Biotechnol 33:543–548. https://doi.org/10.1038/nbt.3198
Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F (2013) Multiplex genome engineering using CRISPR/Cas systems. Science. https://doi.org/10.1126/science.1231143
Cui Y, Niu Y, Zhou J, Chen Y, Cheng Y, Li S, Ai Z, Chu C, Wang H, Zheng B, Chen X, Sha J, Guo X, Huang X, Ji W (2018) Generation of a precise Oct4-hrGFP knockin cynomolgus monkey model via CRISPR/Cas9-assisted homologous recombination. Cell Res 28:383–386. https://doi.org/10.1038/cr.2018.10
Deveau H, Barrangou R, Garneau JE, Labonté J, Fremaux C, Boyaval P, Romero DA, Horvath P, Moineau S (2008) Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J Bacteriol 190:1390–1400. https://doi.org/10.1128/JB.01412-07
Dugar G, Leenay RT, Eisenbart SK, Bischler T, Aul BU, Beisel CL, Sharma CM (2018) CRISPR RNA-dependent binding and cleavage of endogenous RNAs by the Campylobacter jejuni Cas9. Mol Cell 69:839–905. https://doi.org/10.1016/j.molcel.2018.01.032
Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, Sander JD (2013) High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol 31:822–826. https://doi.org/10.1038/nbt.2623
Gao L, Cox DBT, Yan WX, Manteiga JC, Schneider MW, Yamano T, Nishimasu H, Nureki O, Crosetto N, Zhang F (2017) Engineered Cpf1 variants with altered PAM specificities increase genome targeting range. Nat Biotechnol 35:789–792. https://doi.org/10.1038/nbt.3900.Engineered
Gao N, Zhang C, Hu Z, Li M, Wei J, Wang Y, Liu H (2020) Characterization of Brevibacillus laterosporus Cas9 (BlatCas9) for mammalian genome editing. Front Cell Dev Biol. https://doi.org/10.3389/fcell.2020.583164
Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, Liu DR (2017) Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature 551:464–471. https://doi.org/10.1038/nature24644
Gaudelli NM, Lam DK, Rees HA, Solá-Esteves NM, Barrera LA, Born DA, Edwards A, Gehrke JM, Lee SJ, Liquori AJ, Murray R, Packer MS, Rinaldi C, Slaymaker IM, Yen J, Young LE, Ciaramella G (2020) Directed evolution of adenine base editors with increased activity and therapeutic application. Nat Biotechnol 38:892–900. https://doi.org/10.1038/s41587-020-0491-6
Gehrke JM, Cervantes O, Clement MK, Wu Y, Zeng J, Bauer DE, Pinello L, Joung JK (2018) An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities. Nat Biotechnol 36:977–982. https://doi.org/10.1038/nbt.4199
Gilbert LA, Larson MH, Leonardo M, Zairan L, Brar GA, Torress SE, Stern-Ginossar N, Onn B, Doudna JA (2013) CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154:442–451
Grünewald J, Zhou R, Garcia SP, Iyer S, Lareau CA, Aryee MJ, Joung JK (2019a) Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors. Nature 569:433–437. https://doi.org/10.1038/s41586-019-1161-z
Grünewald J, Zhou R, Iyer S, Lareau CA, Garcia SP, Aryee MJ, Joung JK (2019b) CRISPR DNA base editors with reduced RNA off-target and self-editing activities. Nat Biotechnol 37:1041–1048. https://doi.org/10.1038/s41587-019-0236-6
Grünewald J, Zhou R, Lareau CA, Garcia SP, Miller BR, Langner LM, Hsu JY, Aryee MJ, Joung K (2020) A dual-deaminase CRISPR base editor enables concurrent adenine and cytosine editing. 38:861–864. https://doi.org/10.1038/s41587-020-0535-y.A
Hall DB, Struhl K (2002) The VP16 activation domain interacts with multiple transcriptional components as determined by protein-protein cross-linking in vivo. J Biol Chem 277:46043–46050. https://doi.org/10.1074/jbc.M208911200
Han P, Deem MW (2017) Non-classical phase diagram for virus bacterial coevolution mediated by clustered regularly interspaced short palindromic repeats. J R Soc Interface. https://doi.org/10.1098/rsif.2016.0905
Hilton IB, D'Ippolito AM, Vockley CM, Thakore PI, Crawford GE, Reddy TE, Gersbach CA (2015) Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat Biotechnol 33(5):510–517. https://doi.org/10.1038/nbt.3199
Hirano H, Gootenberg, Jonathan S, Horii T, Abudayyeh OO, Kimura M, Hsu PD, Nakane T, Ishitani R, Hatada I, Zhang F, Nishimasu H, Nureki O (2016) Structure and engineering of Francisella novicida Cas9. Cell 164:277–294. https://doi.org/10.1016/j.cell.2016.01.039.Structure
Hsu JY, Anzalone AV, Grünewald J, Lam KC, Shen MW, Liu DR, Joung JK, Pinello L (2020) PrimeDesign software for rapid and simplified design of prime editing guide RNAs. BioRxiv. https://doi.org/10.1101/2020.05.04.077750
Hu JH, Miller SM, Geurts MH, Tang W, Chen L, Sun N, Zeina CM, Gao X, Rees HA, Lin Z, Liu DR (2018) Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Nature 556:57–63. https://doi.org/10.1038/nature26155
Hu Z, Wang S, Zhang C, Gao N, Li M, Wang D, Wang D, Liu D, Liu H, Ong SG, Wang H, Wang Y (2020) A compact cas9 ortholog from staphylococcus auricularis (sauricas9) expands the DNA targeting scope. PLoS Biol 18:e3000686. https://doi.org/10.1371/JOURNAL.PBIO.3000686
Jiang W, Feng S, Huang S, Yu W, Li G, Yang G, Liu Y, Zhang Y, Zhang L, Hou Y, Chen J, Chen J, Huang X (2018) BE-PLUS: a new base editing tool with broadened editing window and enhanced fidelity. Cell Res 28:855–861. https://doi.org/10.1038/s41422-018-0052-4
Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E (2012) A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity. Science 337:816–822
Jo DH, Koo T, Cho CS, Kim JH, Kim JS, Kim JH (2019) Long-term effects of in vivo genome editing in the mouse retina using Campylobacter jejuni Cas9 expressed via adeno-associated virus. Mol Ther 27:130–136. https://doi.org/10.1016/j.ymthe.2018.10.009
Kanarek N, Keys HR, Cantor JR, Lewis CA, Chan SH, Kunchok T, Abu-Remaileh M, Freinkman E, Schweitzer LD, Sabatini DM (2018) Histidine catabolism is a major determinant of methotrexate sensitivity. Nature 559:632–636. https://doi.org/10.1038/s41586-018-0316-7
Kim YG, Cha J, Chandrasegaran S (1996) Hybrid restriction enzymes: Zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci USA 93:1156–1160. https://doi.org/10.1073/pnas.93.3.1156
Kim E, Koo T, Park SW, Kim D, Kim K, Cho HY, Song DW, Lee KJ, Jung MH, Kim S, Kim JH, Kim JH, Kim JS (2017a) In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni. Nat Commun 8(1). https://doi.org/10.1038/ncomms14500
Kim YB, Komor AC, Levy JM, Packer MS, Zhao KT, Liu DR (2017b) Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions. Nat Biotechnol 35:371–376. https://doi.org/10.1038/nbt.3803
Kim S, Koo T, Jee HG, Cho HY, Lee G, Lim DG, Shin HS, Kim JS (2018) CRISPR RNAs trigger innate immune responses in human cells. Genom Res 28:367–373. https://doi.org/10.1101/gr.231936.117
Kim HK, Yu G, Park J, Min S, Lee S, Yoon S, Kim HH (2020) Predicting the efficiency of prime editing guide RNAs in human cells. Nat Biotechnol 39:198–206. https://doi.org/10.1038/s41587-020-0677-y
Kingdom U, Kingdom U, London F, Health N, Foundation S, Kingdom U, Kingdom U (2017) Two distinct RNase activities of CRISPR-C2c2 enable guide RNA processing and RNA detection. Nature 21:129–139. https://doi.org/10.1038/nature19802.Two
Kleinstiver BP, Prew MS, Tsai SQ, Nguyen NT, Topkar VV, Zheng Z, Joung JK (2015a) Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition. Nat Biotechnol 33:1293–1298. https://doi.org/10.1038/nbt.3404
Kleinstiver BP, Prew MS, Tsai SQ, Topkar VV, Nguyen NT, Zheng Z, Gonzales APW, Li Z, Peterson RT, Yeh JRJ, Aryee MJ, Joung JK (2015b) Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature 523:481–485. https://doi.org/10.1038/nature14592
Kleinstiver BP, Pattanayak V, Prew MS, Tsai SQ, Nguyen NT, Zheng Z, Joung JK (2016) High-fidelity CRISPR-Cas9 nucleases with undetectable genome-wide off-target effects. Nature 529:490–495. https://doi.org/10.1038/nature16526
Kleinstiver BP, Sousa AA, Walton RT, Tak YE, Hsu JY, Clement K, Welch MM, Horng JE, Malagon-Lopez J, Scarfò I, Maus MV, Pinello L, Aryee MJ, Joung JK (2019) Engineered CRISPR–Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing. Nat Biotechnol 37:276–282. https://doi.org/10.1038/s41587-018-0011-0
Knott GJ, East-Seletsky A, Cofsky JC, Holton JM, Charles E, O’Connell MR, Doudna JA (2017) Guide-bound structures of an RNA-targeting A-cleaving CRISPR-Cas13a enzyme. Nat Struct Mol Biol 24:825–833. https://doi.org/10.1038/nsmb.3466
Koblan LW, Doman JL, Wilson C, Levy JM, Tay T, Newby GA, Maianti JP, Raguram A, Liu DR (2018) Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nat Biotechnol 36:843–848. https://doi.org/10.1038/nbt.4172
Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR (2016) Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533:420–424. https://doi.org/10.1038/nature17946
Komor AC, Zhao KT, Packer MS, Gaudelli NM, Waterbury AL, Koblan LW, Kim YB, Badran AH, Liu DR (2017) Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity. Sci Adv 3:1–9. https://doi.org/10.1126/sciadv.aao4774
Koo T, Park SW, Jo DH, Kim D, Kim JH, Cho HY, Kim J, Kim JH, Kim JS (2018) CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration. Nat Commun 9:1855. https://doi.org/10.1038/s41467-018-04175-y
Koonin EV, Makarova KS, Zhang F (2017) Diversity, classification and evolution of CRISPR-Cas systems. Curr Opin Microbiol 37:67–78. https://doi.org/10.1016/j.mib.2017.05.008
Lee JK, Jeong E, Lee J, Jung M, Shin E, Kim Y, Lee K, Jung I, Kim D, Kim S, Kim JS (2018) Directed evolution of CRISPR-Cas9 to increase its specificity. Nat Commun 9:3048. https://doi.org/10.1038/s41467-018-05477-x
Li S, Zhang X, Wang W, Guo X, Wu Z, Du W, Zhao Y, Xia L (2018) Expanding the scope of CRISPR/Cpf1-mediated genome editing in rice. Mol Plant 11:995–998. https://doi.org/10.1016/j.molp.2018.03.009
Lin Q, Zong Y, Xue C, Wang S, Jin S, Zhu Z, Wang Y, Anzalone AV, Raguram A, Doman JL, Liu DR, Gao C (2020) Prime genome editing in rice and wheat. Nat Biotechnol 38:582–585. https://doi.org/10.1038/s41587-020-0455-x
Liu XS, Wu H, Ji X, Stelzer Y, Wu X, Czauderna S, Shu J, Dadon D, Young RA, Jaenisch R (2016) Editing DNA methylation in the mammalian genome. Cell 167:233-247.e17. https://doi.org/10.1016/j.cell.2016.08.056
Liu L, Li X, Ma J, Li Z, You L, Wang J, Wang M, Zhang X, Wang Y (2017) The molecular architecture for RNA-guided RNA cleavage by Cas13a. Cell 170:714-726.e10. https://doi.org/10.1016/j.cell.2017.06.050
Liu Z, Chen M, Chen S, Deng J, Song Y, Lai L, Li Z (2018a) Highly efficient RNA-guided base editing in rabbit. Nat Commun. https://doi.org/10.1038/s41467-018-05232-2
Liu Z, Lu Z, Yang G, Huang S, Li G, Feng S, Liu Y, Li J, Yu W, Zhang Y, Chen J, Sun Q, Huang X (2018b) Efficient generation of mouse models of human diseases via ABE- and BE-mediated base editing. Nat Commun. https://doi.org/10.1038/s41467-018-04768-7
Liu M, Rehman S, Tang X, Gu K, Fan Q, Chen D, Ma W (2019) Methodologies for improving HDR efficiency. Front Genet 9:691. https://doi.org/10.3389/fgene.2018.00691
Liu TY, Doudna JA (2020) Chemistry of Class 1 CRISPR-Cas effectors: binding, editing, and regulation. J Biol Chem 295:14473–14487. https://doi.org/10.1074/jbc.REV120.007034
Liu Y, Li X, He S, Huang S, Li C, Chen Y, Liu Z, Huang X, Wang X (2020) Efficient generation of mouse models with the prime editing system. Cell Discov. https://doi.org/10.1038/s41421-020-0165-z
Lu Y, Xue J, Deng T, Zhou X, Yu K, Deng L, Huang M, Yi X, Liang M, Wang Y, Shen H, Tong R, Wang W, Li L, Song J, Li J, Su X, Ding Z, Gong Y, Zhu J, Wang Y, Zou B, Zhang Y, Li Y, Zhou L, Liu Y, Yu M, Wang Y, Zhang X, Yin L, Xia X, Zeng Y, Zhou Q, Ying B, Chen C, Wei Y, Li W, Mok T (2020) Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer. Nat Med 26:732–740. https://doi.org/10.1038/s41591-020-0840-5
Maeder ML, Linder SJ, Cascio VM, Fu Y, Ho QH, Joung JK (2013) CRISPR RNA-guided activation of endogenous human genes. Nat Methods 10:977–979. https://doi.org/10.1038/nmeth.2598
Makarova KS, Koonin EV (2015) Annotation and classification of CRISPR-Cas systems. Methods Mol Biol 1311:47–75. https://doi.org/10.1007/978-1-4939-2687-9_4
Makarova KS, Wolf YI, Alkhnbashi OS, Costa F, Shah SA, Saunders SJ, Barrangou R, Brouns SJJ, Charpentier E, Haft DH, Horvath P, Moineau S, Mojica FJM, Terns RM, Terns MP, White MF, Yakunin AF, Garrett RA, Van Der Oost J, Backofen R, Koonin EV (2015) An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol 13:722–736. https://doi.org/10.1038/nrmicro3569
Makarova KS, Wolf YI, Koonin EV (2018) Classification and nomenclature of CRISPR-Cas systems: where from here? Cris J 1:325–336. https://doi.org/10.1089/crispr.2018.0033
Mao Z, Bozzella M, Seluanov A, Gorbunova V (2008) Comparison of nonhomologous end joining and homologous recombination in human cells. DNA Repair 7:1765–1771. https://doi.org/10.1016/j.dnarep.2008.06.018
Marraffini LA, Sontheimer EJ (2010) CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nat Rev Genet. https://doi.org/10.1038/nrg2749
Miller JC, Holmes MC, Wang J, Guschin DY, Lee YL, Rupniewski I, Beausejour CM, Waite AJ, Wang NS, Kim KA, Gregory PD, Pabo CO, Rebar EJ (2007) An improved zinc-finger nuclease architecture for highly specific genome editing. Nat Biotechnol 25:778–785. https://doi.org/10.1038/nbt1319
Miller SM, Wang T, Randolph PB, Arbab M, Shen MW, Huang TP, Matuszek Z, Newby GA, Rees HA, Liu DR (2020) Continuous evolution of SpCas9 variants compatible with non-G PAMs. Nat Biotechnol 38:471–481. https://doi.org/10.1038/s41587-020-0412-8
Mohanraju P, Makarova KS, Zetsche B, Zhang F, Koonin EV, Van Der Oost J (2016) Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems. Science. https://doi.org/10.1126/science.aad5147
Mushtaq M, Bhat JA, Mir ZA, Sakina A, Ali S, Singh AK, Tyagi A, Salgotra RK, Dar AA, Bhat R (2018) CRISPR/Cas approach: a new way of looking at plant-abiotic interactions. J Plant Physiol 224–225:156–162. https://doi.org/10.1016/j.jplph.2018.04.001
Nishida K, Arazoe T, Yachie N, Banno S, Kakimoto M, Tabata M, Mochizuki M, Miyabe A, Araki M, Hara KY, Shimatani Z, Kondo A (2016) Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Science. https://doi.org/10.1126/science.aaf8729
Nishimasu H, Yamano T, Gao L, Zhang F, Ishitani R, Nureki O (2017) Structural basis for the altered PAM recognition by engineered CRISPR-Cpf1. Mol Cell 67(1):139–147.e2. https://doi.org/10.1016/j.molcel.2017.04.019
Pinilla-Redondo R, Mayo-Muñoz D, Russel J, Garrett RA, Randau L, Sørensen SJ, Shah SA (2020) Type IV CRISPR-Cas systems are highly diverse and involved in competition between plasmids. Nucleic Acids Res 48:2000–2012. https://doi.org/10.1093/nar/gkz1197
Porto EM, Komor AC, Slaymaker IM, Yeo GW (2020) Base editing: advances and therapeutic opportunities. Nat Rev Drug Discov 19:839–859. https://doi.org/10.1038/s41573-020-0084-6
Pyzocha NK, Chen S (2018) Diverse Class 2 CRISPR-Cas effector proteins for genome engineering applications. ACS Chem Biol 13:347–356
Ran FA, Cong L, Yan WX, Scott DA, Gootenberg JS, Kriz AJ, Zetsche B, Shalem O, Wu X, Makarova KS, Koonin EV, Sharp PA, Zhang F (2015) In vivo genome editing using Staphylococcus aureus Cas9. Nature 520:186–191. https://doi.org/10.1038/nature14299
Rees HA, Wilson C, Doman JL, Liu DR (2019) Analysis and minimization of cellular RNA editing by DNA adenine base editors. Sci Adv. https://doi.org/10.1126/sciadv.aax5717
Richter MF, Zhao KT, Eton E, Lapinaite A, Newby GA, Thuronyi BW, Wilson C, Koblan LW, Zeng J, Bauer DE, Doudna JA, Liu DR (2020) Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity. Nat Biotechnol 38:883–891. https://doi.org/10.1038/s41587-020-0453-z
Rojo FP, Nyman RKM, Johnson AAT, Navarro MP, Ryan MH, Erskine W, Kaur P (2018) CRISPR-cas systems: ushering in the new genome editing era. Bioengineered 9:214–221. https://doi.org/10.1080/21655979.2018.1470720
Ryu SM, Koo T, Kim K, Lim K, Baek G, Kim ST, Kim HS, Kim D, Lee H, Chung E, Kim JS (2018) Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy. Nat Biotechnol 36(6):536–539. https://doi.org/10.1038/nbt.4148
Shapiro J, Iancu O, Jacobi AM, McNeill MS, Turk R, Rettig GR, Amit I, Tovin-Recht A, Yakhini Z, Behlke MA, Hendel A (2020) Increasing CRISPR efficiency and measuring its specificity in HSPCs using a clinically relevant system. Mol Ther - Methods Clin Dev 17:1097–1107. https://doi.org/10.1016/j.omtm.2020.04.027
Shmakov S, Abudayyeh OO, Makarova KS, Wolf YI, Gootenberg JS, Semenova E, Minakhin L, Joung J, Konermann S, Severinov K, Zhang F, Koonin EV (2015) Discovery and functional characterization of diverse class 2 CRISPR-Cas systems. Mol Cell 60:358–397. https://doi.org/10.1016/j.molcel.2015.10.008
Slaymaker IM, Gao L, Zetsche B, Scott DA, Yan WX, Zhang F (2016) Rationally engineered Cas9 nucleases with improved specificity. Science 351:84–88. https://doi.org/10.1126/science.aad5227
Stemmer M, Thumberger T, Del Sol Keyer M, Wittbrodt J, Mateo JL (2015) CCTop: an intuitive, flexible and reliable CRISPR/Cas9 target prediction tool. PLoS One 10:e0124633. https://doi.org/10.1371/journal.pone.0124633
Strecker J, Ladha A, Gardner Z, Schmid-Burgk JL, Makarova KS, Koonin EV, Zhang F (2019) RNA-guided DNA insertion with CRISPR-associated transposases. Science 364:48–53. https://doi.org/10.1126/science.aax9181
Szlachta K, Kuscu C, Tufan T, Adair SJ, Shang S, Michaels AD, Mullen MG, Fischer NL, Yang J, Liu L, Trivedi P, Stelow EB, Stukenberg PT, Parsons JT, Bauer TW, Adli M (2018) CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response. Nat Commun. https://doi.org/10.1038/s41467-018-06676-2
Tanenbaum ME, Gilbert LA, Qi LS, Weissman JS, Vale RD (2014) A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell 159:635–646. https://doi.org/10.1016/j.cell.2014.09.039
Thakore PI, D’Ippolito AM, Song L, Safi A, Shivakumar NK, Kabadi AM, Reddy TE, Crawford GE, Gersbach CA (2015) Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements. Nat Methods 12:1143–1149. https://doi.org/10.1038/nmeth.3630
Thuronyi BW, Koblan LW, Levy JM, Yeh WH, Zheng C, Newby GA, Wilson C, Bhaumik M, Shubina-Oleinik O, Holt JR, Liu DR (2019) Continuous evolution of base editors with expanded target compatibility and improved activity. Nat Biotechnol. https://doi.org/10.1038/s41587-019-0193-0
van der Oost J, Jore MM, Westra ER, Lundgren M, Brouns SJJ (2009) CRISPR-based adaptive and heritable immunity in prokaryotes. Trends Biochem Sci 34:401–407. https://doi.org/10.1016/j.tibs.2009.05.002
Walton RT, Christie KA, Whittaker MN, Kleinstiver BP (2020) Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants. Science 368:290–296. https://doi.org/10.1126/science.aba8853
Wang Y, Wang B, Xie H, Ren Q, Liu X, Li F, Lv X, He X, Cheng C, Deng R, Li J, Zhao J, Song Z, Gu F (2019) Efficient human genome editing using SaCas9 ribonucleoprotein complexes. Biotechnol J 14:e1800689. https://doi.org/10.1002/biot.201800689
Wang J, Zhang C, Feng B (2020) The rapidly advancing Class 2 CRISPR-Cas technologies: a customizable toolbox for molecular manipulations. J Cell Mol Med 24:3256–3270. https://doi.org/10.1111/jcmm.15039
Westra ER, Levin BR (2020) It is unclear how important CRISPR-Cas systems are for protecting natural populations of bacteria against infections by mobile genetic elements. Proc Natl Acad Sci USA 117:27777–27785
Xu Z, Li Y, Li M, Xiang H, Yan A (2021) Harnessing the type I CRISPR-Cas systems for genome editing in prokaryotes. Environ Microbiol 23:542–558. https://doi.org/10.1111/1462-2920.15116
Yamada M, Watanabe Y, Gootenberg JS, Hirano H, Ran FA, Nakane T, Ishitani R, Zhang F, Nishimasu H, Nureki O (2017) Crystal structure of the minimal Cas9 from Campylobacter jejuni reveals the molecular diversity in the CRISPR-Cas9 systems. Mol Cell 65:1109-1121.e3. https://doi.org/10.1016/j.molcel.2017.02.007
Yang H, Ren S, Yu S, Pan H, Li T, Ge S, Zhang J, Xia N (2020) Methods favoring homology-directed repair choice in response to CRISPR/Cas9 induced-double strand breaks. Int J Mol Sci 21:6461. https://doi.org/10.3390/ijms21186461
Zetsche B, Gootenberg JS, Abudayyeh OO, Slaymaker IM, Makarova KS, Essletzbichler P, Volz SE, Joung J, Van Der Oost J, Regev A, Koonin EV, Zhang F (2015) Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163:759–771. https://doi.org/10.1016/j.cell.2015.09.038
Zetsche B, Heidenreich M, Mohanraju P, Fedorova I, Kneppers J, DeGennaro EM, Winblad N, Choudhury SR, Abudayyeh OO, Gootenberg JS, Wu WY, Scott DA, Severinov K, van der Oost J, Zhang F (2017) Multiplex gene editing by CRISPR–Cpf1 using a single crRNA array. Nat Biotechnol 35(1):31–34. https://doi.org/10.1038/nbt.3737
Zhang B (2020) CRISPR/Cas gene therapy. J Cell Physiol 236:2459–2481. https://doi.org/10.1002/jcp.30064
Zhang Y, Heidrich N, Ampattu BJ, Gunderson CW, Seifert HS, Schoen C, Vogel J, Sontheimer EJ (2013) Processing-independent CRISPR RNAs limit natural transformation in Neisseria meningitidis. Mol Cell 50:488–503. https://doi.org/10.1016/j.molcel.2013.05.001
Zhang Y, Ge X, Yang F, Zhang L, Zheng J, Tan X, Jin ZB, Qu J, Gu F (2014) Comparison of non-canonical PAMs for CRISPR/Cas9-mediated DNA cleavage in human cells. Sci Rep 4:5405. https://doi.org/10.1038/srep05405
Zhang X, Zhu B, Chen L, Xie L, Yu W, Wang Y, Li L, Yin S, Yang L, Hu H, Han H, Li Y, Wang L, Chen G, Ma X, Geng H, Huang W, Pang X, Yang Z, Wu Y, Siwko S, Kurita R, Nakamura Y, Yang L, Liu M, Li D (2020) Dual base editor catalyzes both cytosine and adenine base conversions in human cells. Nat Biotechnol 38:856–860. https://doi.org/10.1038/s41587-020-0527-y
Zhang M, Eshraghian EA, Jammal O, Al Zhang Z, Zhu X (2021) CRISPR technology: the engine that drives cancer therapy. Biomed Pharmacother. https://doi.org/10.1016/j.biopha.2020.111007
Zhao D, Li J, Li S, Xin X, Hu M, Price MA, Rosser SJ, Bi C, Zhang X (2021) Glycosylase base editors enable C-to-A and C-to-G base changes. Nat Biotechnol 39:35–40. https://doi.org/10.1038/s41587-020-0592-2
Zhou C, Sun Y, Yan R, Liu Y, Zuo E, Gu C, Han L, Wei Y, Hu X, Zeng R, Li Y, Zhou H, Guo F, Yang H (2019) Off-target RNA mutation induced by DNA base editing and its elimination by mutagenesis. Nature 571:275–278. https://doi.org/10.1038/s41586-019-1314-0
Zhu H, Misel L, Graham M, Robinson ML, Liang C (2016) CT-Finder: a web service for CRISPR optimal target prediction and visualization. Sci Rep 6:25516. https://doi.org/10.1038/srep25516
Acknowledgements
This work was supported by grants from the National Research Foundation of Korea [2021R1C1C1005851; T Koo] and the Ministry of Trade, Industry & Energy, South Korea [20012445; T Koo].
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original article was revised as the Fig. 2d was erroneously published. The original article has been corrected.
Rights and permissions
About this article
Cite this article
Song, M., Koo, T. Recent advances in CRISPR technologies for genome editing. Arch. Pharm. Res. 44, 537–552 (2021). https://doi.org/10.1007/s12272-021-01336-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-021-01336-4